Delayed-onset of multiple cutaneous infantile hemangiomas due to propranolol: a case report

Pediatrics
Rocío Porcel ChacónJuan Navarro Morón

Abstract

Infantile hemangiomas are the most common vascular tumors in childhood. In view of its proven effectiveness in such cases, propranolol is the drug of choice. We present the case of a male infant who started treatment with propranolol shortly after birth due to heart disease. After 7 months, when the patient had suffered various respiratory exacerbations, this treatment was suspended. One week later, multiple skin lesions (ie, multifocal infantile hemangiomas) began to appear, with no extracutaneous involvement. It was decided to resume treatment with propranolol, although at lower doses than before, and the skin lesions improved rapidly, with some disappearing completely. Treatment was definitively withdrawn at age 16 months, with only slight recurrence of the lesions. The case described is of multifocal infantile hemangiomas without extracutaneous involvement appearing beyond the neonatal period after treatment with propranolol beginning in the first days of life. The details of the case support the hypothesis that this drug is not only therapeutic but also plays a prophylactic role against infantile hemangiomas. In turn, this supports the recent proposal that this drug may be useful in preventing the growth and spread of tumo...Continue Reading

Citations

Jul 12, 2016·Stress : the International Journal on the Biology of Stress·O KrizanovaK Pacak
Apr 1, 2018·The Journal of Dermatology·Shinji KagamiTatsuo Katori
Jun 29, 2018·The Journal of Dermatology·Shinji KagamiTatsuo Katori

❮ Previous
Next ❯

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Related Papers

Current Opinion in Otolaryngology & Head and Neck Surgery
Lisa M Buckmiller
Dermatologic Therapy
Cristina Ciudad BlancoRicardo Suárez Fernández
Plastic and Reconstructive Surgery
Will J M HolmesSe-Hwang Liew
© 2021 Meta ULC. All rights reserved